A growing body of evidence has illuminated that LSAMP was inactivated and loss of expression due to DNA methylation modifications and acted as a tumor suppressor gene in osteosarcoma [44, 45], acute myeloid leukemia [25], renal carcinoma [46] and ovarian carcinoma [47]. The gene discussed is LSAMP; the disease is ovarian carcinoma.